All Topics
All Topics
Technology
Technology
Design
Design
Programming
Programming
Science
Science
News
News
Gaming
Gaming
Entertainment
Entertainment
Business
Business
Finance
Finance
Sports
Sports
Health
Health
Food
Food
Travel
Travel
Art
Art
Music
Music
Books
Books
Education
Education
Politics
Politics
Personal
Personal
No algorithm. No AI slop. No ads. Just RSS. Pro-human. Indie writers. Real journalism. Open web. Chronological. Hand toasted.

Cohort Study Evaluates Age at Onset and Family History as Predictors for Genetic Testing in Parkinson Disease

By

;

1d ago· 10 min readenInsight

Summary

This cohort study evaluates the association between age at onset (AAO) and family history in Parkinson disease patients who carry pathogenic genetic variants. The study analyzes data from four major datasets (GP2, MDSGene, PD GENEration, and ROPAD) to determine optimal AAO thresholds for genetic testing. The findings suggest that AAO alone or combined with family history can help predict genetic forms of Parkinson disease, with performance curves showing varying sensitivity across different age thresholds. The research aims to improve genetic testing criteria and counseling for Parkinson disease patients.

Key quotes

· 3 pulled
Figure 1 shows performance curves for predicting any genetic form of Parkinson disease using AAO alone or in combination with positive family history across 4 datasets.
The study evaluates the association between age at onset and family history of Parkinson disease in patients who carry pathogenic variants.
Area under the receiver operating characteristic curve (ROC) for predicting any genetic form of Parkinson disease using AAO alone or in combination with positive family history.
Snippet from the RSS feed
This cohort study evaluates the association between age at onset and family history of Parkinson disease in patients who carry pathogenic variants.

You might also wanna read

Experimental pill daraxonrasib extends survival in advanced pancreatic cancer patients, study finds

Researchers reported that daraxonrasib, a novel experimental pill, helped patients with advanced pancreatic cancer live longer by blocking a

npr.org·5h ago

GeneSkin Develops mRNA Therapy Targeting Skin Stem Cells for Rejuvenation and Hair Growth

GeneSkin is developing a novel mRNA therapy targeting basal stem cells in the skin to address a wide range of dermatological issues includin

wyss.harvard.edu·8h ago

First human trial begins for drug that could regrow missing teeth

Kyoto University Hospital has launched the first human trial of TRG-035, a drug designed to regrow teeth in adults by blocking a protein tha

boingboing.net·1d ago

Japanese researchers develop vitamin K-like compounds that may help convert brain cells into neurons

Japanese researchers have developed a new family of vitamin K-like molecules that may help immature brain cells transition into neurons. Whi

zmescience.com·1d ago

International trial shows DNA test could help many breast cancer patients avoid chemotherapy

A new international trial presented at the American Society of Clinical Oncology conference suggests that millions of breast cancer patients

bbc.co.uk·1d ago

Single Infusion of Gene-Editing Therapy VERVE-102 Shows Promise for Inherited High Cholesterol

An experimental gene-editing therapy called VERVE-102, developed by Verve Therapeutics (a subsidiary of Eli Lilly), shows promise in treatin

discovermagazine.com·1d ago